Quality of life among total laryngectomized patients undergoing speech rehabilitation: correlation between several instruments

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.75, article ID e2035, 9p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: The aim of this study was to correlate several instruments currently used for the assessment of the quality of life of patients who underwent total laryngectomy and speech rehabilitation. METHODS: A cross-sectional, observational study was conducted with 38 patients after total laryngectomy and speech therapy aiming to develop oesophageal speech. The patients were divided into the following two groups (19 participants each): speakers and non-speakers. The quality of life instruments used were as follows: visual analogue scale (VAS); Voice Handicap Index (VHI); Voice-Related Quality of Life (V-RQOL); Functional Assessment of Cancer Therapy - Head & Neck (FACT-H & N); European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30); European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck (EORTC QLQ-H & N35); and University of Washington Quality of Life (UW-QOL). RESULTS: The V-RQOL global health domain exhibited a strong correlation with the VHI. The EORTC QLQ-C30 exhibited a moderate to strong correlation with the EORTC QLQ-H&N35 functional domain in both groups. The EORTC QLQ-C30 functional domain exhibited a strong to moderate correlation with all other instruments in both groups. The UW-QOL exhibited a moderate to strong correlation with the VHI and EORTC QLQ-C30 in both groups. CONCLUSION: The EORTC QLQ-C30, EORTC QLQ-H&N35 and UW-QOL were the instruments that most correlated with the remaining instruments, indicating that any of the three can be used to assess the quality of life of the target population regardless of oesophageal voice development.
Palavras-chave
Quality of Life, Laryngectomy, Alaryngeal, Speech, Head and Neck Neoplasms
Referências
  1. AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365
  2. Algave Danielle Patricia, 2015, Rev. CEFAC, V17, P58, DOI 10.1590/1982-021620158413
  3. Allegra E, 2019, PSYCHOL RES BEHAV MA, V12, P675, DOI 10.2147/PRBM.S212793
  4. Antin F, 2020, EUR ANN OTORHINOLARY, pS1879, DOI [10.1016/j.anorl. 2020.06.006, DOI 10.1016/J.AN0RL.2020.06.006]
  5. Behlau M, 2004, J VOICE, P9187, DOI [10.1016/j.jvoice.2020.07.007, DOI 10.1016/J.JV0ICE.2020.07.007]
  6. Behlau M, 2011, J VOICE, V25, P354, DOI 10.1016/j.jvoice.2009.09.007
  7. Bjordal K, 1999, J CLIN ONCOL, V17, P1008, DOI 10.1200/JCO.1999.17.3.1008
  8. BLANCO MB, 2011, ACTA OTORRINOLARINGO, V62, P103, DOI 10.1016/J.OTORRI.2010.09.009
  9. Bornbaum CC, 2014, AM J SPEECH-LANG PAT, V23, P196, DOI 10.1044/2013_AJSLP-13-0024
  10. Bozan A, 2015, EUR ARCH OTO-RHINO-L, V272, P1967, DOI 10.1007/s00405-015-3600-2
  11. BVS APS, AT PRIM SAUD
  12. Correia Maria Eduarda, 2016, Rev. CEFAC, V18, P923, DOI 10.1590/1982-0216201618423115
  13. Costa Érika Beatriz de Morais, 2014, Rev. CEFAC, V16, P967, DOI 10.1590/1982-021620145913
  14. da Silva AP, 2015, J VOICE, V29, P382, DOI 10.1016/j.jvoice.2014.09.002
  15. Dantas RO, 2005, DYSPHAGIA, V20, P101, DOI 10.1007/s00455-004-0027-0
  16. Davatz GC, 2011, THESIS
  17. Andrade Fabiana Paula de, 2012, Rev. bras. epidemiol., V15, P781, DOI 10.1590/S1415-790X2012000400010
  18. del Rio Valeiras M, 2002, ACTA OTORRINOLARINGO, V53, P413, DOI [10.1016/S0001-6519(02)78330-1, DOI 10.1016/S0001-6519(02)78330-1]
  19. Eadie TL, 2012, OTOLARYNG HEAD NECK, V146, P959, DOI 10.1177/0194599812437315
  20. Fayers P., 2001, EORTC QLQ C30 SCORIN, V3rd ed.
  21. Filipovska-Musanovic M, 2012, MED GLAS, V9, P287
  22. Fouquet ML, 2009, FOLIA PHONIATR LOGO, V61, P29, DOI 10.1159/000191471
  23. FRITH C, 1985, J COMMUN DISORD, V18, P475, DOI 10.1016/0021-9924(85)90034-6
  24. Gasparini G, 2009, J VOICE, V23, P76, DOI 10.1016/j.jvoice.2007.04.005
  25. Guibert M, 2011, EUR ANN OTORHINOLARY, V128, P218, DOI 10.1016/j.anorl.2011.02.010
  26. Gutsmann H, 1908, Z LARYNG, V1, P221
  27. Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347
  28. HASSAN SJ, 1993, HEAD NECK-J SCI SPEC, V15, P485, DOI 10.1002/hed.2880150603
  29. Hogikyan ND, 1999, J VOICE, V13, P557, DOI 10.1016/S0892-1997(99)80010-1
  30. Jacobson BH., 1997, AM J SPEECH LANG PAT, V6, P66, DOI [10.1044/1058-0360.0603.66, DOI 10.1044/1058-0360.0603.66]
  31. Karlsen T, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.07.009
  32. Kazi R, 2010, EUR J CANCER CARE, V19, P703, DOI 10.1111/j.1365-2354.2010.01193.x
  33. Kucuk H, 2015, EUR ARCH OTO-RHINO-L, V272, P1245, DOI 10.1007/s00405-014-3066-7
  34. List MA, 1996, CANCER-AM CANCER SOC, V77, P2294, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S
  35. Lu D, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.10.025
  36. MOOLENAARBIJL A, 1953, ANN OTO RHINOL LARYN, V62, P979, DOI 10.1177/000348945306200405
  37. Morete MC, 2010, REVISTA DOR, V11, P74
  38. Mu JW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011545
  39. Nemr K., 2015, REV BRAS CIR CABEC P, V44, P42
  40. Nemr K, 2002, REV BRAS OTORRINOLAR, V68, P805
  41. Nemr K, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e174
  42. Oliveira IB, 2017, AUDIOL COMMUN RES, V22, pe1743
  43. Pellicani AD, 2017, LARYNGOSCOPE, V127, P405, DOI 10.1002/lary.26031
  44. Perry A, 2015, INT J LANG COMM DIS, V50, P467, DOI 10.1111/1460-6984.12148
  45. Robertson SM, 2012, HEAD NECK-J SCI SPEC, V34, P59, DOI 10.1002/hed.21692
  46. Rossi VC, 2014, BRAZ J OTORHINOLAR, V80, P403, DOI 10.1016/j.bjorl.2014.07.005
  47. Rosso M, 2012, COLLEGIUM ANTROPOL, V36, P115
  48. Sahin M, 2015, DIS ESOPHAGUS, V28, P151, DOI 10.1111/dote.12188
  49. Sanabria A, 2018, ENT-EAR NOSE THROAT, V97, P83, DOI 10.1177/014556131809700323
  50. Sawada NO, 2006, REV BRAS CANCEROL, V52, P323
  51. Scott AJ, 2019, J LARYNGOL OTOL, V133, P129, DOI 10.1017/S0022215119000215
  52. Seeman M, 1926, ARCH KLIN CHIR, V140, P285
  53. Singer S, 2014, HEAD NECK-J SCI SPEC, V36, P359, DOI 10.1002/hed.23305
  54. Singer S, 2013, QUAL LIFE RES, V22, P1927, DOI 10.1007/s11136-012-0325-1
  55. Souza FGR, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-1281-z
  56. Tiple C, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.196609
  57. Varghese BT, 2011, ACTA OTO-LARYNGOL, V131, P310, DOI 10.3109/00016489.2010.526960
  58. Vartanian JG, 2006, HEAD NECK-J SCI SPEC, V28, P1115, DOI 10.1002/hed.20464
  59. Wepman JA, 1953, J SPEECH HEAR DISORD, V18, P247, DOI 10.1044/jshd.1803.247
  60. Williamson JS, 2011, ANN ROY COLL SURG, V93, P591, DOI 10.1308/147870811X13137608455253
  61. Xi SX, 2010, INT J EVID-BASED HEA, V8, P256, DOI 10.1111/j.1744-1609.2010.00177.x